Therapy for breast cancer has made great strides, providing patients with a variety of effective treatment methods based on distinct tumor characteristics. The session "Breast Cancer Therapy" emphasizes the current advances in surgical, medical, and targeted treatments for breast cancer.".
Treatment strategies differ based on cancer type, stage, and receptor status. Surgery, such as lumpectomy or mastectomy, continues as an integral component for localized disease. Medical therapies like chemotherapy, hormone therapy, and targeted therapies—such as HER2 inhibitors—are employed to kill cancer cells and prevent recurrence. Treatment is increasingly based on individualized plans guided by genetic profiling and biomarker testing, allowing clinicians to choose the best therapies for each patient.
This session also discusses new strategies, such as immunotherapy, antibody-drug conjugates, and combination regimens, which have been shown to enhance survival and reduce side effects. Supportive care, such as psychosocial care, rehabilitation, and lifestyle modification, is highlighted to maximize quality of life during and beyond treatment.
The audience will learn about the latest clinical practice, cutting-edge therapies, and research that is building the future of breast cancer treatment. This session emphasizes how multidisciplinary strategies and personalized treatment are enhancing outcomes and providing new hope for patients globally."
Welcome to the Cancer and Oncology Conference 2026, where global researchers, clinicians, and academics meet to share advances in cancer biology, precision medicine, diagnostics, therapies, and global solutions for patient care.
